Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Local anaesthesia; parenterally for the acute treatment of ventricular arrhythmias occurring after myocardial infarction or during cardiac procedures such as cardiac surgery or cardiac catheterization; drug of choice for the treatment of ventricular premature contractions [VPCs] associated with myocardial infarction; status epilepticus as a last resort.
Local Anaesthesia: use the lowest dose needed to provide effective anaesthesia.Adults: the dose not greater than 200 mg. For spinal anaesthesia not greater than 100 mg. Children:the dose not more than 3mg/kg. Use in Cardiac Arrhythmias -Adults: 50 -100 mg IV at a rate of about 25-50 mg per minute. No more than 200 - 300 mg within 1 hr
Serious side effects are uncommon. Drowsiness; dizziness; disorientation; confusion; lightheadedness; psychosis; apprehension; tinnitus; visual disturbances including amblyopia or diplopia; nausea; vomiting; paraesthesia; sensations of heat, cold, or numbness; difficulty swallowing; dyspnea; and slurred speech; muscle twitching or tremors, seizures, unconsciousness, coma, and respiratory depression; hypersensitivity reaction; hypotension, arrhythmias, heart block; local thrombophlebitis.
Store as labelled. Keep out of reach of children.